Skip to main content
Top
Published in: Medical Microbiology and Immunology 4/2008

01-12-2008 | Original Investigation

Increased pathogenesis and inflammation of airways from respiratory syncytial virus infection in T cell deficient nude mice

Authors: Juan Zhou, Xi-Qiang Yang, Zhou Fu, Xiao-Dong Zhao, Li-Ping Jiang, Li-Jia Wang, Yu-Xia Cui

Published in: Medical Microbiology and Immunology | Issue 4/2008

Login to get access

Abstract

Respiratory syncytial virus (RSV) infection is ubiquitous and leads to various outcomes between immunocompetent and immunocompromised individuals. This study aimed to compare RSV infection and inflammatory responses between immunocompetent BALB/c mice and immunodeficient nude mice. RSV titers in both infected BALB/c mice and nude mice peaked on the third day post-inoculation, but the nude mice had longer lasting and higher levels of viral replication. RSV infection induced a more severe grade of pulmonary histopathology and larger numbers of leukocytes in airways of nude mice than that of BALB/c mice. RSV infection increased pulmonary macrophages and natural killer (NK) cells in both strains of mice. Furthermore, infected nude mice had larger numbers of pulmonary macrophages and NK cells than infected BALB/c mice. Whereas the RSV infected BALB/c mice secreted more tumor necrosis factor –α (TNF-α), interleukin-12 (IL-12), interferon-γ (IFN-γ) and IL-10 than control BALB/c mice, the infected nude mice had higher levels of TNF-α, IL-12 and IL-10 than the infected BALB/c mice. The inflammation induced by RSV infection did not correspond with the immune response of T cells. Macrophages and NK cells were potent immunocytes and inflammatory cells in RSV infection especially when T lymphocytes were deficient. Therefore, nude mice may be a good model for severe and persistent RSV infection in immunocompromised hosts.
Literature
1.
go back to reference Black CP (2003) Systematic review of the biology and medical management of respiratory syncytial virus infection. Respir Care 48:209–233PubMed Black CP (2003) Systematic review of the biology and medical management of respiratory syncytial virus infection. Respir Care 48:209–233PubMed
2.
go back to reference Mejias A, Chavez-Buneo S, Jafri HS, Ramilo O (2005) Respiratory syncytial virus infections: old challenges and new opportunities. Pediatr Infect Dis J 24(11 Suppl):S189–S196PubMed Mejias A, Chavez-Buneo S, Jafri HS, Ramilo O (2005) Respiratory syncytial virus infections: old challenges and new opportunities. Pediatr Infect Dis J 24(11 Suppl):S189–S196PubMed
3.
go back to reference DeVincenzo JP (2005) Factors predicting childhood respiratory syncytial virus severity: what they indicate about pathogenesis. Pediatr Infect Dis J 24(11 Suppl):S177–S183PubMed DeVincenzo JP (2005) Factors predicting childhood respiratory syncytial virus severity: what they indicate about pathogenesis. Pediatr Infect Dis J 24(11 Suppl):S177–S183PubMed
4.
go back to reference Welliver RC (2003) Review of epidemiology and clinical risk factors for severe respiratory syncytial virus (RSV) infection. J Pediatr 143(suppl 5):112–117 Welliver RC (2003) Review of epidemiology and clinical risk factors for severe respiratory syncytial virus (RSV) infection. J Pediatr 143(suppl 5):112–117
5.
go back to reference Braciale TJ (2005) Respiratory syncytial virus and T cells: interplay between the virus and the host adaptive immune system. Proc Am Thorac Soc 2:141–146PubMedCrossRef Braciale TJ (2005) Respiratory syncytial virus and T cells: interplay between the virus and the host adaptive immune system. Proc Am Thorac Soc 2:141–146PubMedCrossRef
6.
go back to reference Taylor G, Stott EJ, Hayle AJ (1985) Cytotoxic lymphocytes in the lungs of mice infected with respiratory syncytial virus. J Gen Virol 66:2533–2538PubMedCrossRef Taylor G, Stott EJ, Hayle AJ (1985) Cytotoxic lymphocytes in the lungs of mice infected with respiratory syncytial virus. J Gen Virol 66:2533–2538PubMedCrossRef
7.
go back to reference Cannon MJ, Stott EJ, Taylor G, Askonas BA (1987) Clearance of persistent respiratory syncytial virus infections in immunodeficient mice following transfer of primed T cells. Immunology 62:133–138PubMed Cannon MJ, Stott EJ, Taylor G, Askonas BA (1987) Clearance of persistent respiratory syncytial virus infections in immunodeficient mice following transfer of primed T cells. Immunology 62:133–138PubMed
8.
go back to reference Cianci C, Yu KL, Combrink K, Pearce NSB, Wang A, Civiello R, Voss S, Luo G, Kadow K, Genovesi EV (2004) Orally active fusion inhibitor of respiratory syncytial virus. Antimicrob Agents Chemother 48:413–422PubMedCrossRef Cianci C, Yu KL, Combrink K, Pearce NSB, Wang A, Civiello R, Voss S, Luo G, Kadow K, Genovesi EV (2004) Orally active fusion inhibitor of respiratory syncytial virus. Antimicrob Agents Chemother 48:413–422PubMedCrossRef
9.
go back to reference Jafri HS, Chavez-Bueno S, Mejias A, Gomez AM, Rios AM, Nassi SS, Yusuf M, Kapur P, Hardy RD, Hatfield J, Rogers BB, Krisher K, Ramilo O (2004) Respiratory syncytial virus induces pneumonia, cytokine response, airway obstruction, and chronic inflammatory infiltrates associated with long-term airway hyperresponsiveness in mice. J Infect Dis 189:1856–1865PubMedCrossRef Jafri HS, Chavez-Bueno S, Mejias A, Gomez AM, Rios AM, Nassi SS, Yusuf M, Kapur P, Hardy RD, Hatfield J, Rogers BB, Krisher K, Ramilo O (2004) Respiratory syncytial virus induces pneumonia, cytokine response, airway obstruction, and chronic inflammatory infiltrates associated with long-term airway hyperresponsiveness in mice. J Infect Dis 189:1856–1865PubMedCrossRef
10.
go back to reference Cimolai N, Taylor GP, Mah D, Morrison BJ (1992) Definition and application of a histopathological scheme for an animal model of acute Mycoplasma pneumoniae pulmonary infection. Microb Immunol 36:465–478 Cimolai N, Taylor GP, Mah D, Morrison BJ (1992) Definition and application of a histopathological scheme for an animal model of acute Mycoplasma pneumoniae pulmonary infection. Microb Immunol 36:465–478
11.
go back to reference McNamara PS, Smyth RL (2002) The pathogenesis of respiratory syncytial virus disease in childhood. Br Med Bull 61:13–28PubMedCrossRef McNamara PS, Smyth RL (2002) The pathogenesis of respiratory syncytial virus disease in childhood. Br Med Bull 61:13–28PubMedCrossRef
12.
go back to reference Winslow GM, Yager E, Shilo K, Collins DN, Chu FK (1998) Infection of the laboratory mouse with the intracellular pathogen Ehrlichia chaffeensis. Infect Immunol 66:3892–3899 Winslow GM, Yager E, Shilo K, Collins DN, Chu FK (1998) Infection of the laboratory mouse with the intracellular pathogen Ehrlichia chaffeensis. Infect Immunol 66:3892–3899
13.
go back to reference Stagg AJ, Tuffrey M, Woods C, Wunderink E, Knight SC (1998) Protection against ascending infection of the genital tract by Chlamydia trachomatis is associated with recruitment of major histocompatibility complex class II antigen-presenting cells into uterine tissue. Infect Immunol 66:3535–3544 Stagg AJ, Tuffrey M, Woods C, Wunderink E, Knight SC (1998) Protection against ascending infection of the genital tract by Chlamydia trachomatis is associated with recruitment of major histocompatibility complex class II antigen-presenting cells into uterine tissue. Infect Immunol 66:3535–3544
14.
go back to reference Kimpen JL (2001) Respiratory syncytial virus and asthma. The role of monocytes. Am J Respir Crit Care Med 163:S7–S9PubMed Kimpen JL (2001) Respiratory syncytial virus and asthma. The role of monocytes. Am J Respir Crit Care Med 163:S7–S9PubMed
15.
go back to reference Blanco JC, Boukhvalova MC, Hemming P, Ottolini MG, Prince GA (2005) Prospects of antiviral and anti-inflammatory therapy for respiratory syncytial virus infection. Expert Rev Anti Infect Ther 3:945–955PubMedCrossRef Blanco JC, Boukhvalova MC, Hemming P, Ottolini MG, Prince GA (2005) Prospects of antiviral and anti-inflammatory therapy for respiratory syncytial virus infection. Expert Rev Anti Infect Ther 3:945–955PubMedCrossRef
16.
go back to reference Openshaw PJ (2005) Antiviral immune responses and lung inflammation after respiratory syncytial virus infection. Proc Am Thorac Soc 2:121–125PubMedCrossRef Openshaw PJ (2005) Antiviral immune responses and lung inflammation after respiratory syncytial virus infection. Proc Am Thorac Soc 2:121–125PubMedCrossRef
17.
go back to reference Panuska JR, Merolla R, Rebert NA, Hoffmann SP, Tsivitse P, Cirino NM, Silverman RH, Rankin JA (1995) Respiratory syncytial virus induces interleukin-10 by human alveolar macrophages. Suppression of early cytokine production and implications for incomplete immunity. J Clin Invest 96:2445–2453PubMedCrossRef Panuska JR, Merolla R, Rebert NA, Hoffmann SP, Tsivitse P, Cirino NM, Silverman RH, Rankin JA (1995) Respiratory syncytial virus induces interleukin-10 by human alveolar macrophages. Suppression of early cytokine production and implications for incomplete immunity. J Clin Invest 96:2445–2453PubMedCrossRef
18.
go back to reference Tripp RA, Moore M, Jones L, Sullender W, Winter J, Anderson LJ (1999) Respiratory syncytial virus G and/or SH protein alters Th1 cytokines, natural killer cells, and neutrophils responding to pulmonary infection in BALB/c mice. J Virol 73:7099–7107PubMed Tripp RA, Moore M, Jones L, Sullender W, Winter J, Anderson LJ (1999) Respiratory syncytial virus G and/or SH protein alters Th1 cytokines, natural killer cells, and neutrophils responding to pulmonary infection in BALB/c mice. J Virol 73:7099–7107PubMed
19.
go back to reference Hussell T, Openshaw PJ (1998) Intracellular interferon-gexpression in natural killer cells precedes lung CD8+ T cell recruitment during respiratory syncytial virus infection. J Gen Virol 79:2593–2601PubMed Hussell T, Openshaw PJ (1998) Intracellular interferon-gexpression in natural killer cells precedes lung CD8+ T cell recruitment during respiratory syncytial virus infection. J Gen Virol 79:2593–2601PubMed
20.
go back to reference Rutigliano JA, Graham BS (2004) Prolonged production of TNF-alpha exacerbates illness during respiratory syncytial virus infection. J Immunol 173:3408–3417PubMed Rutigliano JA, Graham BS (2004) Prolonged production of TNF-alpha exacerbates illness during respiratory syncytial virus infection. J Immunol 173:3408–3417PubMed
21.
go back to reference Wang SZ, Bao YX, Rosenberger CL, Tesfaigzi Y, Stark JM, Harrod KS (2004) IL-12p40 and IL-18 modulate inflammatory and immune responses to respiratory syncytial virus infection. J Immunol 173:4040–4049PubMed Wang SZ, Bao YX, Rosenberger CL, Tesfaigzi Y, Stark JM, Harrod KS (2004) IL-12p40 and IL-18 modulate inflammatory and immune responses to respiratory syncytial virus infection. J Immunol 173:4040–4049PubMed
22.
go back to reference Durbin JE, Johnson TR, Durbin RK, Mertz SE, Morotti RA, Peebles RS, Graham BS (2002) The role of IFN in respiratory syncytial virus pathogenesis. J Immunol 168:2944–2952PubMed Durbin JE, Johnson TR, Durbin RK, Mertz SE, Morotti RA, Peebles RS, Graham BS (2002) The role of IFN in respiratory syncytial virus pathogenesis. J Immunol 168:2944–2952PubMed
23.
go back to reference Wang H, Peters N, Schwarze J (2006) Plasmacytoid dendritic cells limit viral replication, pulmonary inflammation, and airway hyperresponsiveness in respiratory syncytial virus infection. J Immunol 177:6263–6270PubMed Wang H, Peters N, Schwarze J (2006) Plasmacytoid dendritic cells limit viral replication, pulmonary inflammation, and airway hyperresponsiveness in respiratory syncytial virus infection. J Immunol 177:6263–6270PubMed
24.
go back to reference Ruan Y, Okamoto Y, Matsuzaki Z, Endo S, Matsuoka T, Kohno T, Chazono H, Eiko I, Tsubota K, Saito I (2001) Suppressive effect of locally produced interleukin-10 on respiratory syncytial virus infection. Immunology 104:355–360PubMedCrossRef Ruan Y, Okamoto Y, Matsuzaki Z, Endo S, Matsuoka T, Kohno T, Chazono H, Eiko I, Tsubota K, Saito I (2001) Suppressive effect of locally produced interleukin-10 on respiratory syncytial virus infection. Immunology 104:355–360PubMedCrossRef
25.
go back to reference Schmidt AC, Johnson TR, Peter JM, Braciale TJ, Falsey AR, Anderson LJ, Werta GW, Groothuis TJ, Prince GA, Melero JA, Graham BS (2004) Respiratory syncytial virus and other pneumoviruses: a review of the international symposium—RSV 2003. Virus Res 106:1–13PubMedCrossRef Schmidt AC, Johnson TR, Peter JM, Braciale TJ, Falsey AR, Anderson LJ, Werta GW, Groothuis TJ, Prince GA, Melero JA, Graham BS (2004) Respiratory syncytial virus and other pneumoviruses: a review of the international symposium—RSV 2003. Virus Res 106:1–13PubMedCrossRef
Metadata
Title
Increased pathogenesis and inflammation of airways from respiratory syncytial virus infection in T cell deficient nude mice
Authors
Juan Zhou
Xi-Qiang Yang
Zhou Fu
Xiao-Dong Zhao
Li-Ping Jiang
Li-Jia Wang
Yu-Xia Cui
Publication date
01-12-2008
Publisher
Springer-Verlag
Published in
Medical Microbiology and Immunology / Issue 4/2008
Print ISSN: 0300-8584
Electronic ISSN: 1432-1831
DOI
https://doi.org/10.1007/s00430-007-0067-9

Other articles of this Issue 4/2008

Medical Microbiology and Immunology 4/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.